CAPÍTULO V EL DIA FELIZ
9. Bulas pontificias de la Balma
This I hope will help you remember
O-‐ Oral ulcer R-‐ malar Rash D-‐ Discoid rash
E-‐ Exaggerated photosensitivity
R-‐ Renal disorders (proteinuria, cellular casts)
H-‐ Haematology disorders (haemolytic anemia, leukopenia, lymphopenia, thrombocytopenia)
I-‐ Immunological disorders (anti-‐DNA antibody, anti-‐Sm, antiphospholipid antibody) S-‐ Serositis
A-‐ ANA
N-‐ Neurological problems A-‐ Arthritis
1. 95% of SLE are ANA +ve.
2. 50% dsDNA +ve, but is specific for SLE.
3. 25% RF +ve.
Prof Esha : Even if you forget the pnemonic, remember there are 4 mucocutaneous features,(malar rash,photosensitive rash,discoid rash and oral ulcer),4 systemic involvement( CNS,serositis,kidney and arthritis) and 3 lab finding(
Heamatology,Immunology and ANA stands on its own) Recent addition in lab features are positive anti Sm antibody,antiphospholipis antibody,and low complements,along with direct positive coomb's test.
36) ON MONOFILAMENT testing Dear Yin Ling,
Are you familiar with Monofilament sensory testing devices which consist of a single strand of nylon (typically attached to a plastic or paper handle) that can produce a
characteristic downward force when buckled onto a surface?
Are you aware that they come in different sizes?
The monofilaments commonly used to screen for sensory neuropathy are 4.17, 5.07, and 6.10. The use of a single 5.07 monofilament is the accepted standard in medical practice to screen for the minimum level of protective sensation in the foot. Ten grams of reproducible buckling stress force are required to bend the 5.07
monofilament.
Why do we use monofilament testing? Why do we not just use our usual pin, cotton and tuning fork??
When the monofilament bends, its tip is exerting a pressure of 10 grams (therefore this monofilament is often referred to as the 10gram monofilament). If the patient cannot feel the monofilament at certain specified sites on the foot, he/she has lost enough sensation to be at risk of developing a neuropathic ulcer.
Testing of diabetic patients for protective sensation may be simplified to testing under both first metatarsal heads. If a patient cannot sense the application under either first metatarsal head, he or she probably has lost protective sensation and should be considered to be at risk for undetected injury.
Generally, No person with a foot ulceration could feel the 5.07 (10g) filament, concluding that monofilaments are an effective, inexpensive and simple screening device in identifying the ‘at risk’ foot.\
In contrast, a person who can feel the 10-‐gram filament in the selected sites is at reduced risk for developing ulcers.
The patient must not watch while the examiner applies the filament.
Pre-‐Test the monofilament on the patient's hand or sternum so he/she knows what to anticipate.
Typically we test five sites and document the findings. The number of sites may vary from centre to centre.
Apply the monofilament perpendicular to the skin's surface Apply sufficient force to cause the filament to bend or buckle
Pls Apply the filament along the perimeter and NOT ON an ulcer, callus, scar or necrotic tissue. Do not allow the filament to slide across the skin or make repetitive contact at the test site.
Have patients identify at which time they were touched. To avoid guessing, randomize the sequence of applying the filament throughout the examination.
Patients should have their feet examined at least annually for impaired sense of pressure, vibration, pain, or temperature, which is characteristic of peripheral neuropathy.
Pressure sense is best tested with a monofilament esthesiometer as this picks up patients with high risk of diabetic ulcers
Yin Ling,
The overall risk of developing a diabetic foot ulcer is determined by a combination of factors.
In general, the risk is higher if:
Neuropathy is more severe (because more sensation is lost and multiple small trauma breaks the skin)
Peripheral vascular disease is more severe (because there is less circulation to bring enough oxygen to repair tissue damage. Just look at the dry black feet with curled up nails and you see feet which are deserts)
There are coexisting abnormalities of the shape of the foot which make the local effects of neuropathy or vascular disease more severe (because it increases local pressure and callus; heavens let us ban all those fashionable but cruel footwear that ladies wear as it deforms the feet into an abnormal shape)
The patient who is unable to practise reasonable self care of the feet and to prevent
trauma (because there are more chances of damaging the feet with fungal infections in the webs, poor nail hygiene and cutting)
The diabetic control is very poor (because of susceptibility to infection and poor wound healing)
There is a past history of foot ulceration due to diabetes (because all the above factors persist)
Dear Yin Ling,
People often ask which is the earliest abnormality and expect a single answer that is dogmatic. The truth is however much more complex and the answer is "It varies!"
Sensory or sensorimotor distal polyneuropathy is the most common of the diabetic neuropathies. With this, numbness and paresthesias begin in the toes, and gradually and insidiously ascend to involve the feet and lower legs. Very common, we see it all the time.
With a sensory or sensorimotor distal polyneuropathy, both lightly myelinated and unmyelinated small nerve fibers and the myelinated large nerve fibers are affected.
Small and large fiber dysfunction occurs in varying combinations;
however, in most cases, the earliest deficits involve the small nerve fibers.
Features characteristic of a small fiber peripheral neuropathy include burning or lancinating pain, hyperalgesia, paresthesias and dysesthesias, **deficits in pain and temperature perception** leading to foot ulceration.
Features characteristic of large fiber peripheral neuropathy include the loss of position and vibration perception sense and loss of deep tendon reflexes, tested with tuning fork and Ankle jerks.
So based on this what will you, yin ling, select as a mode for screening which must of course pick up the pathology early!?
37) ON ISOLATED RAISED GAMMA GT